先天性脊柱侧凸患者循环游离线粒体DNA的改变
本研究为病例对照研究,纳入35例先天性脊柱侧凸(CS)患者和32例年龄匹配对照,检测血浆游离DNA。结果显示CS患者循环游离线粒体DNA(ccf mt-DNA)的ND1和CYTC水平显著降低,而游离核DNA(ccf n-DNA)无显著差异;ROC曲线分析显示ccf mt-DNA对CS有可靠预测灵敏度与特异度,但无法区分ICVAS分型。
要点
- CS患者血浆ccf mt-DNA(ND1和CYTC)水平较对照显著降低。
- ccf n-DNA水平在CS与对照间无显著差异。
- ccf mt-DNA对CS预测有可靠灵敏度与特异度,但无法区分ICVAS分型。
核心结论
- 先天性脊柱侧凸患者血浆ccf mt-DNA水平显著低于对照,提示其可能预测CS发生或发展。
研究设计与样本
- 病例对照研究,纳入35例CS患者和32例年龄匹配对照,采集外周血浆进行ccf DNA分析。
主要发现
- CS患者血浆ccf mt-DNA的ND1和CYTC水平在总体及按性别分析中均较对照显著降低。
- 血浆ccf n-DNA水平在CS与对照间无显著差异。
- 按ICVAS分类,S-SDV与M-SDV之间ccf mt-DNA和ccf n-DNA均无差异。
- ROC曲线分析显示ccf mt-DNA对CS预测在总体中有可靠灵敏度与特异度,但未能区分不同ICVAS类型。
关键数值与推荐
- 采用定量PCR检测ccf n-DNA和ccf mt-DNA水平,并进行相关性分析。
- 使用ROC曲线分析ccf n-DNA和ccf mt-DNA对不同特征的灵敏度与特异度。
临床怎么用
- 该发现对临床实践意义有限,但提示ccf mt-DNA可能预测CS发生或发展。
- 未来研究可关注ccf mt-DNA在胚胎发育中的作用及其作为CS产前筛查标志物的可能性。
局限性
- 研究证据等级为4级。
- 作者指出该发现对临床实践意义有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY DESIGN: Case-control study. OBJECTIVE: The aim of this study was to estimate the relationship between circulating cell-free DNA (ccf DNA) and clinical parameters of patients with congenital scoliosis (CS). SUMMARY OF BACKGROUND DATA: CS is a complex spinal deformity characteristic of congenital vertebral malformations. Although numerous studies have centered on the etiology of CS, the cause of CS remains unclear. Previously, we reported that circulating cell-free DNA (ccf DNA) is altered in adolescent idiopathic scoliosis (AIS). However, the relationship between ccf DNA and the clinical parameters of patients with CS remains unclear. METHODS: The plasma of peripheral blood from 35 patients with CS and 32 age-matched controls was collected for ccf DNA analysis. Quantitative PCR was used to detect ccf n-DNA and ccf mt-DNA levels, and correlation analyses between ccf n-DNA and ccf mt-DNA levels were conducted. Receiver-operating characteristic (ROC) curves were used to analyze the sensitivity and specificity of ccf n-DNA and ccf mt-DNA levels to different characteristics. RESULTS: The plasma ccf mt-DNA levels of both ND1 and CYTC were significantly decreased in patients with CS compared with levels in controls both in total and by sex, whereas the plasma ccf n-DNA levels showed no significant difference. There is no difference in both ccf mt-DNA and ccf n-DNA between S-SDV and M-SDV according to The International Consortium for Vertebral Anomalies and Scoliosis (ICVAS) classification. The ROC curve analyses showed a reliable sensitivity and specificity of CS predicted by ccf mt-DNA levels in total but failed to distinguish different ICVAS types. CONCLUSION: Significantly decreased plasma ccf mt-DNA levels were observed in patients with CS compared with those in controls. Although this finding has limited significance for clinical practice, it indicates that ccf mt-DNA may predict the onset or development of CS. Further studies should focus on the role of ccf mt-DNA in embryo development and whether ccf mt-DNAs could be considered as a marker for prenatal screening in development disorder like CS.Level of Evidence: 4.
引用
- Yang G, Tang M, Zhang H, et al. Altered Circulating Cell-free Mitochondrial DNA of Patients with Congenital Scoliosis. Spine (Phila Pa 1976). 2021. PMID: 33290375. doi:10.1097/BRS.0000000000003849
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。